TWIN-GPT: Digital Twins for Clinical Trials via Large Language Model
0
Sign in to get full access
Overview
- This paper presents TWIN-GPT, a framework that uses large language models to create digital twins for simulating and optimizing clinical trials.
- The researchers demonstrate how TWIN-GPT can generate virtual patient profiles, predict trial outcomes, and optimize recruitment strategies, all with the goal of improving the clinical trial process.
- The paper builds upon recent advancements in digital twin generators for disease modeling and the potential of large language models for digital diagnostics.
Plain English Explanation
The paper introduces TWIN-GPT, a new system that uses powerful language AI models to create "digital twins" - virtual representations of real people - for clinical trials. The goal is to make the clinical trial process more efficient and effective.
Clinical trials are a crucial part of developing new medical treatments, but they can be complex and expensive to run. TWIN-GPT aims to help by generating virtual patient profiles that can be used to simulate and optimize the trial design.
For example, the language model can create detailed profiles of potential trial participants, including their medical history, demographics, and other relevant characteristics. These virtual patients can then be used to predict how the real-world trial might play out, allowing researchers to fine-tune the recruitment process and trial protocols.
The researchers also show how TWIN-GPT can be used to generate virtual reports on predicted trial outcomes, which could help sponsors and regulators make more informed decisions about which trials to pursue. By providing this kind of rich simulation capability, the hope is that TWIN-GPT can ultimately lead to faster, cheaper, and more successful clinical trials.
Technical Explanation
The core of TWIN-GPT is a large language model that has been fine-tuned on a diverse corpus of medical literature, clinical trial data, and other relevant sources. This allows the model to generate highly realistic virtual patient profiles, complete with detailed medical histories, demographic information, and other attributes.
To create a digital twin, the model takes in a set of seed parameters (e.g., age, gender, disease state) and then iteratively refines the virtual patient profile, drawing on its broad medical knowledge to ensure the outputs are coherent and clinically plausible. The researchers demonstrate how these digital twins can be used to simulate multi-agent clinical trials and predict trial outcomes.
A key innovation of TWIN-GPT is its ability to optimize the clinical trial recruitment process. By generating a large population of digital twins, the system can analyze which combination of participant characteristics is most likely to yield positive trial results. This allows researchers to match patients to clinical trials more effectively, potentially improving enrollment rates and reducing the time and cost associated with running a trial.
Critical Analysis
The TWIN-GPT framework represents an exciting application of large language models to the clinical trial domain. By creating highly realistic digital twins, the system has the potential to meaningfully streamline and optimize the trial process, leading to faster drug development and better patient outcomes.
However, the paper does acknowledge several limitations and areas for further research. For example, the authors note that the current version of TWIN-GPT relies heavily on text-based data and may struggle to incorporate more complex, multimodal information (e.g., imaging data, sensor readings) that is often critical in clinical settings. Expanding the model's capabilities in this direction could be an important next step.
Additionally, the researchers highlight the need for rigorous validation of the digital twins, to ensure they accurately reflect real-world patient populations and trial dynamics. Deploying TWIN-GPT in live clinical trials and comparing its predictions to actual outcomes will be a crucial step in building trust and confidence in the system.
Overall, TWIN-GPT represents a promising step forward in leveraging advanced AI techniques to improve the clinical trial process. As the technology continues to evolve, it will be important to carefully consider the ethical implications, such as ensuring fairness and privacy protections, as digital twins become more widely adopted in healthcare.
Conclusion
The TWIN-GPT framework introduced in this paper demonstrates the potential of large language models to create highly realistic digital twins for simulating and optimizing clinical trials. By generating virtual patient profiles and predicting trial outcomes, TWIN-GPT aims to make the clinical trial process faster, cheaper, and more successful.
While the system shows promise, the researchers acknowledge several areas for further development, such as incorporating multimodal data and rigorously validating the digital twins. As TWIN-GPT and similar technologies continue to advance, it will be crucial to thoughtfully address the ethical considerations surrounding their deployment in healthcare.
Overall, this work represents an exciting step forward in applying cutting-edge AI techniques to improve the efficiency and effectiveness of clinical trials, with the ultimate goal of accelerating the development of new life-saving treatments.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
0
TWIN-GPT: Digital Twins for Clinical Trials via Large Language Model
Yue Wang, Tianfan Fu, Yinlong Xu, Zihan Ma, Hongxia Xu, Yingzhou Lu, Bang Du, Honghao Gao, Jian Wu
Clinical trials are indispensable for medical research and the development of new treatments. However, clinical trials often involve thousands of participants and can span several years to complete, with a high probability of failure during the process. Recently, there has been a burgeoning interest in virtual clinical trials, which simulate real-world scenarios and hold the potential to significantly enhance patient safety, expedite development, reduce costs, and contribute to the broader scientific knowledge in healthcare. Existing research often focuses on leveraging electronic health records (EHRs) to support clinical trial outcome prediction. Yet, trained with limited clinical trial outcome data, existing approaches frequently struggle to perform accurate predictions. Some research has attempted to generate EHRs to augment model development but has fallen short in personalizing the generation for individual patient profiles. Recently, the emergence of large language models has illuminated new possibilities, as their embedded comprehensive clinical knowledge has proven beneficial in addressing medical issues. In this paper, we propose a large language model-based digital twin creation approach, called TWIN-GPT. TWIN-GPT can establish cross-dataset associations of medical information given limited data, generating unique personalized digital twins for different patients, thereby preserving individual patient characteristics. Comprehensive experiments show that using digital twins created by TWIN-GPT can boost the clinical trial outcome prediction, exceeding various previous prediction approaches.
Read more7/2/2024
💬
0
Matching Patients to Clinical Trials with Large Language Models
Qiao Jin, Zifeng Wang, Charalampos S. Floudas, Fangyuan Chen, Changlin Gong, Dara Bracken-Clarke, Elisabetta Xue, Yifan Yang, Jimeng Sun, Zhiyong Lu
Clinical trials are often hindered by the challenge of patient recruitment. In this work, we introduce TrialGPT, a first-of-its-kind large language model (LLM) framework to assist patient-to-trial matching. Given a patient note, TrialGPT predicts the patient's eligibility on a criterion-by-criterion basis and then consolidates these predictions to assess the patient's eligibility for the target trial. We evaluate the trial-level prediction performance of TrialGPT on three publicly available cohorts of 184 patients with over 18,000 trial annotations. We also engaged three physicians to label over 1,000 patient-criterion pairs to assess its criterion-level prediction accuracy. Experimental results show that TrialGPT achieves a criterion-level accuracy of 87.3% with faithful explanations, close to the expert performance (88.7%-90.0%). The aggregated TrialGPT scores are highly correlated with human eligibility judgments, and they outperform the best-competing models by 32.6% to 57.2% in ranking and excluding clinical trials. Furthermore, our user study reveals that TrialGPT can significantly reduce the screening time (by 42.6%) in a real-life clinical trial matching task. These results and analyses have demonstrated promising opportunities for clinical trial matching with LLMs such as TrialGPT.
Read more4/30/2024
0
Large Language Models-Enabled Digital Twins for Precision Medicine in Rare Gynecological Tumors
Jacqueline Lammert, Nicole Pfarr, Leonid Kuligin, Sonja Mathes, Tobias Dreyer, Luise Modersohn, Patrick Metzger, Dyke Ferber, Jakob Nikolas Kather, Daniel Truhn, Lisa Christine Adams, Keno Kyrill Bressem, Sebastian Lange, Kristina Schwamborn, Martin Boeker, Marion Kiechle, Ulrich A. Schatz, Holger Bronger, Maximilian Tschochohei
Rare gynecological tumors (RGTs) present major clinical challenges due to their low incidence and heterogeneity. The lack of clear guidelines leads to suboptimal management and poor prognosis. Molecular tumor boards accelerate access to effective therapies by tailoring treatment based on biomarkers, beyond cancer type. Unstructured data that requires manual curation hinders efficient use of biomarker profiling for therapy matching. This study explores the use of large language models (LLMs) to construct digital twins for precision medicine in RGTs. Our proof-of-concept digital twin system integrates clinical and biomarker data from institutional and published cases (n=21) and literature-derived data (n=655 publications with n=404,265 patients) to create tailored treatment plans for metastatic uterine carcinosarcoma, identifying options potentially missed by traditional, single-source analysis. LLM-enabled digital twins efficiently model individual patient trajectories. Shifting to a biology-based rather than organ-based tumor definition enables personalized care that could advance RGT management and thus enhance patient outcomes.
Read more9/4/2024
📉
0
Digital Twin Generators for Disease Modeling
Nameyeh Alam, Jake Basilico, Daniele Bertolini, Satish Casie Chetty, Heather D'Angelo, Ryan Douglas, Charles K. Fisher, Franklin Fuller, Melissa Gomes, Rishabh Gupta, Alex Lang, Anton Loukianov, Rachel Mak-McCully, Cary Murray, Hanalei Pham, Susanna Qiao, Elena Ryapolova-Webb, Aaron Smith, Dimitri Theoharatos, Anil Tolwani, Eric W. Tramel, Anna Vidovszky, Judy Viduya, Jonathan R. Walsh
A patient's digital twin is a computational model that describes the evolution of their health over time. Digital twins have the potential to revolutionize medicine by enabling individual-level computer simulations of human health, which can be used to conduct more efficient clinical trials or to recommend personalized treatment options. Due to the overwhelming complexity of human biology, machine learning approaches that leverage large datasets of historical patients' longitudinal health records to generate patients' digital twins are more tractable than potential mechanistic models. In this manuscript, we describe a neural network architecture that can learn conditional generative models of clinical trajectories, which we call Digital Twin Generators (DTGs), that can create digital twins of individual patients. We show that the same neural network architecture can be trained to generate accurate digital twins for patients across 13 different indications simply by changing the training set and tuning hyperparameters. By introducing a general purpose architecture, we aim to unlock the ability to scale machine learning approaches to larger datasets and across more indications so that a digital twin could be created for any patient in the world.
Read more5/3/2024